Basics BioAge Labs, Inc. IPO Date: September 26, 2024 Sector: Healthcare Industry: Drug Manufacturers Market Cap: $141.61M Activated in VL: True Average Daily Range Avg Daily Range: $0.41 | 3.95% Avg Daily Range (30 D): $0.10 | 2.51% Avg Daily Range (90 D): $0.13 | 3.04% Institutional Daily Volume Avg Daily Volume: .41M Avg Daily Volume (30 D): .19M Avg Daily Volume (90 D): .21M Trade Size Avg Trade Size (Sh.): 113 Avg Trade Size (Sh.) (30 D): 93 Avg Trade Size (Sh.) (90 D): 107 Institutional Trades Total Inst.Trades: 39 Avg Inst. Trade: $1.54M Avg Inst. Trade (30 D): $.73M Avg Inst. Trade (90 D): $.73M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.19M Avg Closing Trade (30 D): $.64M Avg Closing Trade (90 D): $.64M Avg Closing Volume: 240.99K         News Mar 8, 2025 @ 12:34 PM BIOA LEGAL NEWS: A Class Action was filed on behal... Source: N/A Mar 5, 2025 @ 5:00 PM Deadline Alert: BioAge Labs, Inc. (BIOA) Investors... Source: N/A Mar 3, 2025 @ 9:00 PM BIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman Llc Mar 2, 2025 @ 6:14 PM BIOA DEADLINE ALERT: BioAge Labs (BIOA) Investors ... Source: N/A Mar 2, 2025 @ 2:50 PM BIOA INVESTOR DEADLINE: Robbins Geller Rudman & Do... Source: Robbins Geller Rudman & Dowd Llp Financials   TTM Q1 2025 Q4 2024 Basic EPS $.77 $-.36 $15.13 Diluted EPS $.77 $-.36 $15.13 Revenue $ 1.45M $ 1.45M $ M Gross Profit $ $ $ Net Income / Loss $ -71.05M $ -12.93M $ -21.13M Operating Income / Loss $ -81.83M $ -16.45M $ -25.36M Cost of Revenue $ $ $ Net Cash Flow $ 232.46M $ -96.85M $ 19.74M PE Ratio 5.25